Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 2, 2009

Premium

Invitrogen, a division of Life Technologies, this week introduced the Gibco OptiCho Protein Express Kit for developing serum-free, stable cell lines for biotherapeutic development.

The kit is the first of its kind to provide cells banked under cGMP conditions, the company said in a statement.

The kit incorporates all reagents, protocols, and documentation required to go from gene to stable cell clones "expressing the protein of interest within a completely serum-free environment," Invitrogen said.

The kit is available for use in research but laboratories interested in pursuing regulatory filings and in need of a documentation package can purchase a commercial use license for a one-time fee, and with no maintenance fees or royalties required, the company added.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.